Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization

The pathogenic yeast Candida glabrata has become a public health issue due to the increasing number of echinocandin resistant clinical strains reported. In this study, acquisition and development of resistance to this antifungal class were studied in serial C. glabrata isolates from five patients ad...

Full description

Bibliographic Details
Main Authors: Olga Rivero-Menendez, Patricia Navarro-Rodriguez, Leticia Bernal-Martinez, Gema Martin-Cano, Laura Lopez-Perez, Isabel Sanchez-Romero, Ana Perez-Ayala, Javier Capilla, Oscar Zaragoza, Ana Alastruey-Izquierdo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.01585/full
_version_ 1819129344878968832
author Olga Rivero-Menendez
Patricia Navarro-Rodriguez
Leticia Bernal-Martinez
Leticia Bernal-Martinez
Gema Martin-Cano
Laura Lopez-Perez
Isabel Sanchez-Romero
Ana Perez-Ayala
Javier Capilla
Oscar Zaragoza
Oscar Zaragoza
Ana Alastruey-Izquierdo
Ana Alastruey-Izquierdo
author_facet Olga Rivero-Menendez
Patricia Navarro-Rodriguez
Leticia Bernal-Martinez
Leticia Bernal-Martinez
Gema Martin-Cano
Laura Lopez-Perez
Isabel Sanchez-Romero
Ana Perez-Ayala
Javier Capilla
Oscar Zaragoza
Oscar Zaragoza
Ana Alastruey-Izquierdo
Ana Alastruey-Izquierdo
author_sort Olga Rivero-Menendez
collection DOAJ
description The pathogenic yeast Candida glabrata has become a public health issue due to the increasing number of echinocandin resistant clinical strains reported. In this study, acquisition and development of resistance to this antifungal class were studied in serial C. glabrata isolates from five patients admitted in two Spanish hospitals with a resistant profile against echinocandins associated with different mutations in hot-spot 1 of FKS2 gene. For two of these patients susceptible FKS wild-type isolates obtained prior to resistant ones were also investigated. Isolates were genotyped using multilocus sequence typing and microsatellite length polymorphism techniques, which yielded comparable results. Susceptible and resistant isolates from the same patient had the same genotype, being sequence type (ST) 3 the most prevalent among them. Isolates with different FKS mutations but the same ST were present in the same patient. MSH2 gene alterations were also studied to investigate their correlation with antifungal resistance acquisition but no association was found with antifungal resistance nor with specific genotypes. In vitro exposure to increasing concentrations of micafungin to susceptible isolates developed colonies carrying FKS mutations in agar plates containing a minimum concentration of 0.06 mg/L of micafungin after less than 48 h of exposure. We investigated the correlation between development of resistance and genotype in a set of susceptible strains after being in vitro exposed to micafungin and anidulafungin but no correlation was found. Mutant prevention concentration values and spontaneous growth frequencies after selection with both echinocandins were statistically similar, although FKS mutant colonies were more abundant after micafungin exposure (p < 0.001). Mutation S663P and F659 deletion were the most common ones found after selection with both echinocandins.
first_indexed 2024-12-22T08:42:14Z
format Article
id doaj.art-5835a54a45ef404691d1311bb02fc5b5
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-22T08:42:14Z
publishDate 2019-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-5835a54a45ef404691d1311bb02fc5b52022-12-21T18:32:12ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-07-011010.3389/fmicb.2019.01585466748Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular CharacterizationOlga Rivero-Menendez0Patricia Navarro-Rodriguez1Leticia Bernal-Martinez2Leticia Bernal-Martinez3Gema Martin-Cano4Laura Lopez-Perez5Isabel Sanchez-Romero6Ana Perez-Ayala7Javier Capilla8Oscar Zaragoza9Oscar Zaragoza10Ana Alastruey-Izquierdo11Ana Alastruey-Izquierdo12Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, SpainUnitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Tarragona, SpainMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, SpainSpanish Network for the Research in Infectious Diseases (RD16CIII/0004/0003), Instituto de Salud Carlos III, Madrid, SpainMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, SpainMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, SpainHospital Universitario Puerta de Hierro, Madrid, SpainHospital Universitario 12 de Octubre, Madrid, SpainUnitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Tarragona, SpainMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, SpainSpanish Network for the Research in Infectious Diseases (RD16CIII/0004/0003), Instituto de Salud Carlos III, Madrid, SpainMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, SpainSpanish Network for the Research in Infectious Diseases (RD16CIII/0004/0003), Instituto de Salud Carlos III, Madrid, SpainThe pathogenic yeast Candida glabrata has become a public health issue due to the increasing number of echinocandin resistant clinical strains reported. In this study, acquisition and development of resistance to this antifungal class were studied in serial C. glabrata isolates from five patients admitted in two Spanish hospitals with a resistant profile against echinocandins associated with different mutations in hot-spot 1 of FKS2 gene. For two of these patients susceptible FKS wild-type isolates obtained prior to resistant ones were also investigated. Isolates were genotyped using multilocus sequence typing and microsatellite length polymorphism techniques, which yielded comparable results. Susceptible and resistant isolates from the same patient had the same genotype, being sequence type (ST) 3 the most prevalent among them. Isolates with different FKS mutations but the same ST were present in the same patient. MSH2 gene alterations were also studied to investigate their correlation with antifungal resistance acquisition but no association was found with antifungal resistance nor with specific genotypes. In vitro exposure to increasing concentrations of micafungin to susceptible isolates developed colonies carrying FKS mutations in agar plates containing a minimum concentration of 0.06 mg/L of micafungin after less than 48 h of exposure. We investigated the correlation between development of resistance and genotype in a set of susceptible strains after being in vitro exposed to micafungin and anidulafungin but no correlation was found. Mutant prevention concentration values and spontaneous growth frequencies after selection with both echinocandins were statistically similar, although FKS mutant colonies were more abundant after micafungin exposure (p < 0.001). Mutation S663P and F659 deletion were the most common ones found after selection with both echinocandins.https://www.frontiersin.org/article/10.3389/fmicb.2019.01585/fullCandida glabrataechinocandinsantifungal resistanceFKSMSH2genotyping
spellingShingle Olga Rivero-Menendez
Patricia Navarro-Rodriguez
Leticia Bernal-Martinez
Leticia Bernal-Martinez
Gema Martin-Cano
Laura Lopez-Perez
Isabel Sanchez-Romero
Ana Perez-Ayala
Javier Capilla
Oscar Zaragoza
Oscar Zaragoza
Ana Alastruey-Izquierdo
Ana Alastruey-Izquierdo
Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization
Frontiers in Microbiology
Candida glabrata
echinocandins
antifungal resistance
FKS
MSH2
genotyping
title Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization
title_full Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization
title_fullStr Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization
title_full_unstemmed Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization
title_short Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization
title_sort clinical and laboratory development of echinocandin resistance in candida glabrata molecular characterization
topic Candida glabrata
echinocandins
antifungal resistance
FKS
MSH2
genotyping
url https://www.frontiersin.org/article/10.3389/fmicb.2019.01585/full
work_keys_str_mv AT olgariveromenendez clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT patricianavarrorodriguez clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT leticiabernalmartinez clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT leticiabernalmartinez clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT gemamartincano clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT lauralopezperez clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT isabelsanchezromero clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT anaperezayala clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT javiercapilla clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT oscarzaragoza clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT oscarzaragoza clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT anaalastrueyizquierdo clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization
AT anaalastrueyizquierdo clinicalandlaboratorydevelopmentofechinocandinresistanceincandidaglabratamolecularcharacterization